Persistent Mutation Burden Drives Sustained Anti-Tumor Immune Responses

0
228
Investigators evaluated mutations in regions of the genome that were unlikely to undergo loss in a pan-cancer analysis across 31 tumor types and eight immunotherapy-treated cohorts of patients with non-small-cell lung cancer, melanoma, mesothelioma, and head and neck cancer.
[Nature Medicine]
Full Article